An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

In this section: Cellular & Gene Therapy Products

TECARTUS (brexucabtagene autoleucel)

STN: BL 125703
Proper Name: brexucabtagene autoleucel
Tradename: TECARTUS
Manufacturer: Kite Pharma, Inc.
Indication:

Adult patients with relapsed or refractory mantle cell lymphoma (MCL). New Indication for this supplement: Adult patients with relapsed or refractory (r/r) B-cell
precursor acute lymphoblastic leukemia (ALL)

Product Information

Package Insert - TECARTUS
Demographic Subgroup Information - TECARTUS (brexucabtagene autoleucel)
Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

Top